The Use of Auto-Titrating Continuous Positive Airway Pressure (AutoCPAP) for Obstructive Sleep Apnea Syndrome in Children with Obesity

Sarah Benke; Caroline U A Okorie; MaryAnne A Tablizo

doi:10.3390/children8121204

The Use of Auto-Titrating Continuous Positive Airway Pressure (AutoCPAP) for Obstructive Sleep Apnea Syndrome in Children with Obesity

Children (Basel). 2021 Dec 19;8(12):1204. doi: 10.3390/children8121204.

Authors

Sarah Benke¹, Caroline U A Okorie², MaryAnne A Tablizo^{2

3}

Affiliations

¹ Department of Pediatrics, Valley Children's Hospital, Madera, CA 93636, USA.
² Division of Pediatric Pulmonary and Sleep Medicine, Stanford Children's Health, Lucille Packard Children's Hospital, Palo Alto, CA 94304, USA.
³ Division of Pediatric Pulmonary and Sleep Medicine, Valley Children's Hospital, Madera, CA 93636, USA.

Abstract

Background: Positive airway pressure can be an effective and safe therapy for children with obstructive sleep apnea syndrome (OSAS). Few studies have assessed the safety and efficacy of autoCPAP in pediatric patients with obesity.

Methods: This was a retrospective chart review of children with obesity (Body Mass Index (BMI) > 99th percentile), ages 2-18, diagnosed with OSAS (Obstructive Apnea-Hypopnea Index (OAHI) > 1/h) and used autoCPAP with 30-day adherence. Exclusion criteria included patients with complex comorbidities. Adherence was defined as autoCPAP use ≥4 h/night for at least 21/30 days. Baseline PSG OAHI was compared to the AHI from the 30-day autoCPAP compliance report. We also compared autoCPAP 30-day 95th percentile pressures with the pressures from PAP titration.

Results: The study included 19 children, ranging 5-15 years old. The median BMI was 99.6th percentile and average adherence was 25/30 nights with mean of 7.3 h/night. The median OAHI was 12.3/h on baseline PSG and the 30-day autoCPAP download AHI decreased to 1.7/h. No adverse outcomes were identified. The average difference between 95th percentile autoCPAP pressure and PAP titration pressure was 0.89 cmH20.

Conclusion: Our study suggests autoCPAP is effective and safe for the treatment of OSAS in pediatric patients with obesity. Using autoCPAP may reduce delays in treatment. Additional research is needed to verify the long-term effectiveness of autoCPAP in this population.

Keywords: auto-titrating continuous positive airway pressure; obesity; obstructive sleep apnea; pediatric sleep apnea; positive airway pressure; sleep disordered breathing.